Brief: Qiagen Highlights Molecular Testing Solutions Supporting Response To Growing U.S. Cyclospora Outbreak
15/07/2026 21:08
BRIEF-Qiagen Highlights Molecular Testing Solutions Supporting Response To Growing U.S. Cyclospora Outbreak July 15 (Reuters) - Qiagen NV QIA.DE:
QIAGEN HIGHLIGHTS MOLECULAR TESTING SOLUTIONS SUPPORTING RESPONSE TO GROWING U.S. CYCLOSPORA OUTBREAK
Source text: ID:nBw2Whqcxa
Further company coverage: QIA.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on QIAGEN
See all newsLab testing LBO offers murky result for both sides
Deals of the day-Mergers and acquisitions
Press Digest: Financial Times - October 22
Brief: Qiagen And Eqt Private Equity Announce Agreement On A Recommended Voluntary All-Cash Public Takeover Offer
EQT to buy molecular testing firm Qiagen for $10.8 billion (updated)